PHM seeks to finalize restructuring

Tuesday, November 21, 2017

LAFAYETTE, La. – Patient Home Monitoring on Dec. 15 will ask security holders to vote on splitting the company in two. PHM will become a DME company specializing in delivering and servicing oxygen therapy, sleep apnea treatment and mobility equipment; and Viemed will become a respiratory company specializing in non-invasive vents for patients with COPD, CHF and neuromuscular conditions. PHM announced plans to split into two different companies last year. PHM’s board of directors has unanimously approved the arrangement and recommends that security holders also vote in favor of it. Shares of PHM will continue to be listed for trading on the Toronto Stock Exchange under PHM, and shares of Viemed will be listed under VMD.